MGMT and melanoma: The contribution of MGMT to melanoma resistance to methylating agents seems to be rather dependent on downstream pathways that are capable of recognising the persistent O6-guanine base damage and initiating apoptosis, such as the DNA mismatch repair pathway (MMR).